Comparative proteomic analysis of extracellular proteins reveals secretion of T-kininogen from vascular smooth muscle cells in response to incubation with S-enantiomer of propranolol

Molecular Pharmaceutics

Volumn 5, Issue 5, 2008, Pages 885-890

  Sui, Jianjun ^a   Zhang, Jianhua ^a   Ching, Chi Bun ^a   Chen, Wei Ning ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Bradykinin; Enantiomer; iTRAQ; Propranolol; T kininogen

Indexed keywords

BRADYKININ DERIVATIVE; ISOLEUCYLSERYLBRADYKININ; KININOGEN; PROPRANOLOL; T KININOGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENANTIOMER; LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEOMICS; RAT; SMOOTH MUSCLE FIBER; TANDEM MASS SPECTROMETRY; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; EXTRACELLULAR FLUID; KININOGENS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PEPTIDES; PROPRANOLOL; PROTEOMICS; RATS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEREOISOMERISM;

EID: 56049102396     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp800012x     Document Type: Article

References (27)

1. Johnson, M. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 2006, 117 (1), 18-24.
2. Strader, C. D.; CandeLore, M. R.; Hill, W. S.; Sigal, I. S.; Dixon, R. A. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J. Biol. Chem. 1989, 264 (23), 13572-13578.
3. Minneman, K. P.; Hedberg, A.; Molinoff, P. B. Comparison of betaadrenergic receptor subtypes in mammalian tissues. J. Pharmacol. Exp. Ther. 1979, 211 (3), 502-508.
4. Stiles, G. L.; Taylor, S.; Letkowitz, R. J. Human cardiac betaadrenergic receptor subtype heterogeneity delineated by direct radioligand binding. Life Sci. 1983, 33 (5), 476-483.
5. Taylor, E. N.; Hu, F. B.; Curhan, G. C. Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 2006, 29 (5), 1065-1070.
6. Hanash, S. Integrated global profiling of cancer. Nat. Rev. Cancer 2004, 4 (8), 638-644.
7. Stanley, B. A.; Gundry, R. L.; Cotter, R. J.; Van Eyk, J. E. Heart disease, clinical proteomics and mass spectrometry. Dis. Markers 2004, 20 (3), 167-178.
8. Shiio, Y.; Donohoe, S.; Yi, E. C.; Goodlett, D. R.; Aebersold, R.; Eisenman, R. N. Quantitative proteomic analysis of Myc oncoprotein function. EMBO J. 2002, 21 (19), 5088-5096.
9. Han, D. K.; Eng, J.; Zhou, H.; Aebersold, R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 2001, 19 (10), 946-951.
10. Griffin, T. J.; Gygi, S. P.; Ideker, T., B.; Rist, B.; Eng, J.; Hood, L.; Aebersold, R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 2002, 1 (4), 323-333.
11. Tan, T. L.; Chen, W. A proteomics analysis of cellular proteins associated with HBV genotype-specific HBX: Potential in identification of early diagnostic markers for HCC. J. Clin. Virol. 2005, 33 (4), 293-298.
12. Tyers, M.; Mann, M. From genomics to proteomics. Nature 2003, 422 (6928), 193-197.
13. Goufman, E. I.; Moshkovskii, S. A.; Tikhonova, O. V.; Lokhov, P. G.; Zgoda, V. G.; Serebryakova, M. V.; Toropygin, I. Y.; Vlasova, M. A.; Safarova, M. R.; Makarov, O. V.; Archakov, A. I. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Moscow) 2006, 71 (4), 354-360.
14. Hansen, K. C.; Schmitt-Ulms, G.; Chalkley, R. J.; Hirsch, J.; Baldwin, M. A.; Burlingame, A. L. Mass spectrometric analysis of protein mixtures at low levels using cleavable C-13-isotope-coded affinity tag and multidimensional chromatography. Mol. Cell. Proteomics 2003, 2 (5), 299-314.
15. Zappacosta, F.; Annan, R. N-terminal isotope tagging strategy for quantitative proteomics: Results-driven analysis of protein abundance changes. Anal. Chem. 2004, 76 (22), 6618-6627.
16. Ross, P.; Huang, Y.; Marchese, J.; Williamson, B.; Parker, K.; Hatten, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents. Mol. Cell. Proteomics 2004, 3 (12), 1154-1169.
17. Sui, J. J.; Tan, T. L.; Zhang, J. H.; Ching, C. B.; Chen, W. N. ITRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: Possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J. Proteome Res. 2007, 6 (5), 1643-1651.
18. Benjamini, Y.; Drai, D.; Elmer, G.; Kafkafi, N.; Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125 (1-2), 279-284.
19. Esnard, F.; Gauthier, F. Rat al-cysteine proteinase inhibitor: An acute phase reactant identical with al-acute phase globulin. J. Biol. Chem. 1983, 258 (20), 12443-12447.
20. Miiller-Esterl, W.; Iwanaga, S.; Nakanishi, S. Kininogens revisited. Trends Biol. Sci. 1986, 11 (8), 336-339.
21. Okamoto, H.; Greenbaum, L. M. Isolation and structure of T-kinin. Biochem. Biophys. Res. Commun. 1983, 112 (2), 701-708.
22. Park, S. S.; Thao, H.; Mueller, R. A.; Xu, Z. L. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J. Mol. Cell Cardiol. 2006, 40 (5), 708-716.
23. Regoli, D.; Allogho, S. N.; Rizzi, A.; Gobei, F. J. Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 1998, 348 (1), 1-10.
24. Yin, H.; Chao, J.; Bader, M.; Chao, L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 2007, 28 (7), 1383-1389.
25. Witte, K.; Engelhardt, S.; Janssen, B.; Lohse, M.; Lemmer, B. Circadian and short- term regulation of blood pressure and heart rate in transgenic mice with cardiac overexpression of the beta(1)-adrenoceptor. Chronobiol. Int. 2004, 21 (2), 205-216.
26. Detry, J.; Sellier, P.; Pennaforte, S.; Cokkinos, D.; Marthes, P. Dargie, H. A new concept in the treatment of angina-comparison with propranolol in patients with stable angina. Br. J. Clin. Pharmacol. 1994, 37 (3), 279-288.
27. Shivkumar, K.; Schultz, L.; Goldstein, S.; Gheorghiade, M. Effects of propranolol in patients entered in the beta-blocker heart attack trial with their first myocardial infarction and persistent electro-cardiographic ST-segment depression. Am. Heart J. 1998, 135 (2), 261-267.